Generics Leading Nigerian drugmaker Fidson Healthcare has entered into a partnership with US firms, Immune Therapeutics, GB Pharma and American Hospitals & Resort (AHAR) for the marketing and distribution of a new product, Lodonal (naltrexone hydrochloride), a patent-protected product that is indicated for the management of patients with immune-compromising diseases. 19 February 2016